Answers are grounded in this paper and cite their sources.
This research demonstrates the synthesis of triazole and tetrazole derivatives, suggesting strong binding to breast cancer targets PI3K and HER2.
This study reports the synthesis of novel heterocyclic compounds via a three-step approach: formation of tris(4-aminotriazole-3-thione) (N1) from nitrilotriacetic acid and thiocarbohydrazide, derivatization to Schiff bases (N2–N11) using various aromatic aldehydes, and subsequent conversion to tetrazoles (N12–N19) via reaction with sodium azide. The synthesized compounds were characterized by FT-IR, ¹H-NMR, and ¹³C-NMR. Molecular docking studies against PI3K and HER2 receptors showed strong binding affinities (ΔG values up to -9.8 kcal/mol), indicating promising anticancer potential.
No takes yet. Share an insight, caveat, or question.
Khalaf et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: